November 19, 2012
Many of us who live with HIV are alive today in part because we received effective treatment to clear our hepatitis C (HCV) co-infections. Interferon-boosted Ribavirin was a lifesaver, but the interferon side effects could be rugged.
MedPage Today reports that a triple-drug regimen without interferon has been found in a small study to be highly effective in clearing even treatment-resistant HCV genotype 1. FDA approval for clinical use is still a long way off, but we look forward to a future of effective HCV treatment without interferon.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|What Would an HIV Cure Mean for You?|
|Condomless Anal Sex Rising in U.S. MSM With or Without HIV Infection|
|If We Act to Remove Structural, Behavioral and Social Barriers, We Can End the HIV Epidemic With the Medicines We Already Have|
|This Week in HIV Research: Immune System Differences Could Produce bNAbs; New HIV Infections Are No Longer Falling; and Zoledronic Acid May Prevent Bone Loss|
|What's the Next Game-Changer in HIV Treatment?|